Skip to main content

Reimbursement Policies

08/13/2026

EmblemHealth has updated the following Reimbursement Policies. See revision history for updates and effective dates for the following policies:  

  • Ambulatory Surgical Groupers.
  • Coding Edits Policy (commercial, Medicare, and Medicaid).
  • Preventive Care Services (commercial and Medicaid).

Updated Lab Benefit Management (LBM) Reimbursement Policies:

  • Biomarkers for Myocardial Infarction and Chronic Heart Failure (LBM).
  • Colorectal Cancer (LBM).
  • Coronavirus Testing in the Outpatient Setting (LBM).
  • Diabetes Mellitus Testing (LBM).
  • Gamma-Glutamyl Transferase (LBM).
  • General Inflammation Testing (LBM).
  • Identification of Microorganisms Using Nucleic Acid Probes (LBM).
  • Oral Cancer Screening and Testing (LBM).
  • Pathogen Panel Testing (LBM).
  • Prenatal Screening (Nongenetic) (LBM).
  • Serum Testing for Evidence of Mild Traumatic Brain Injury (LBM).
  • Testing for Alpha-1 Antitrypsin Deficiency (LBM).
  • Urine Culture Testing for Bacteria (LBM).

JP72487 08/2026

Provider Update